Trade Summary
Yesterday, Kilroy Conor, serving as See Remarks at Aura Biosciences, Inc. (AURA), sold 11,738 shares at $7.02 per share, for a total transaction value of $82,401.00. Following this transaction, Kilroy Conor now holds 217,835 shares of AURA.
This sale represents a 5.00% decrease in Kilroy Conor's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Thursday, April 16, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 16, 2026, meaning the disclosure happened on the same day as the trade.
Aura Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.